Literature DB >> 18355505

Risk scores do not predict high mortality after coronary artery bypass surgery in the presence of diastolic dysfunction.

Lorenzo Merello1, Erick Riesle, Javier Alburquerque, Humberto Torres, Ernesto Aránguiz-Santander, Oneglio Pedemonte, Bernhard Westerberg.   

Abstract

BACKGROUND: Although global postoperative mortality after on-pump coronary artery bypass grafting is approximately 3%, in some groups it can be considerably higher. Many conditions are known to increase mortality and have been included in well-known scoring systems; however, left ventricular diastolic dysfunction has not been sufficiently evaluated to identify its predictive value for mortality after coronary artery bypass grafting, nor is it integrated in currently used risk scores.
METHODS: Left ventricular filling pattern was prospectively evaluated in 191 patients scheduled for on-pump coronary artery bypass grafting. A follow-up of survival and complications was made for 30 days postoperatively. Observed mortality was compared with the mortality predicted by the scores of EuroSCORE and Parsonnet.
RESULTS: A correlation was found between diastolic function, the presence of comorbidities, and postoperative survival. There was no mortality in the group with normal filling pattern (0 of 33 patients). In the presence of an alteration of relaxation, mortality was 5 of 129 patients (3.8%); in the pseudonormal group it was 2 of 16 patients (12.5%); and in the restrictive group it was 6 of 13 patients (46.1%; p < 0.01). Parsonnet and EuroSCORE predicted a mortality of 1.5% to 1.6%, 1.5% to 2.0%, 1.5% to 2.2%, and 3.9% to 4.1% for each group, respectively. Mortality in the group with E deceleration time of 150 ms or greater was 2.8% and in the group with E deceleration time less than 150 ms was 17.3% (p < 0.01). Postoperative complications were also more frequent in the group with advanced dysfunction.
CONCLUSIONS: Severe diastolic dysfunction is a strong predictor of adverse outcome and mortality after on-pump coronary artery bypass grafting, and this high risk is not adequately predicted by EuroSCORE and Parsonnet score. Measures of diastolic function should be included in routine preoperative risk assessment.

Entities:  

Mesh:

Year:  2008        PMID: 18355505     DOI: 10.1016/j.athoracsur.2007.12.068

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  Diastolic function: a barometer for cardiovascular risk?

Authors:  Leanne Groban; Dalane W Kitzman
Journal:  Anesthesiology       Date:  2010-06       Impact factor: 7.892

2.  Prognostic value of tissue Doppler-Derived E/e' on early morbid events after cardiac surgery.

Authors:  Leanne Groban; David M Sanders; Timothy T Houle; Benjamin L Antonio; Edi C Ntuen; David A Zvara; Neal D Kon; Edward H Kincaid
Journal:  Echocardiography       Date:  2010-02       Impact factor: 1.724

3.  ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease.

Authors:  Raphael Rosenhek; Bernard Iung; Pilar Tornos; Manuel J Antunes; Bernard D Prendergast; Catherine M Otto; Arie Pieter Kappetein; Janina Stepinska; Jens J Kaden; Christoph K Naber; Esmeray Acartürk; Christa Gohlke-Bärwolf
Journal:  Eur Heart J       Date:  2011-03-15       Impact factor: 29.983

Review 4.  Heart Failure With Preserved Ejection Fraction: A Perioperative Review.

Authors:  Sasha K Shillcutt; M Megan Chacon; Tara R Brakke; Ellen K Roberts; Thomas E Schulte; Nicholas Markin
Journal:  J Cardiothorac Vasc Anesth       Date:  2017-08-30       Impact factor: 2.628

Review 5.  Diastolic dysfunction, cardiovascular aging, and the anesthesiologist.

Authors:  David Sanders; Michael Dudley; Leanne Groban
Journal:  Anesthesiol Clin       Date:  2009-09

6.  Selected Transesophageal Echocardiographic Parameters of Left Ventricular Diastolic Function Predict Length of Stay Following Coronary Artery Bypass Graft-A Prospective Observational Study.

Authors:  Samhati Mondal; Nauder Faraday; Wei Dong Gao; Sarabdeep Singh; Sachidanand Hebbar; Kimberly N Hollander; Thomas S Metkus; Lee A Goeddel; Maria Bauer; Brian Bush; Brian Cho; Stephanie Cha; Stephanie O Ibekwe; Domagoj Mladinov; Noah S Rolleri; Laeben Lester; Jochen Steppan; Rosanne Sheinberg; Nadia B Hensley; Anubhav Kapoor; Jeffrey M Dodd-O
Journal:  J Clin Med       Date:  2022-07-08       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.